4833M 15/850 (Actoplus Met 850 mg / 15 mg)
Generic Name: metformin/pioglitazone
Pill with imprint 4833M 15/850 is White, Elliptical / Oval and has been identified as Actoplus Met 850 mg / 15 mg. It is supplied by Takeda Pharmaceuticals America, Inc..
ActoPlus Met is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. ActoPlus Met 850 mg / 15 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 4833M 15/850
- Generic Name
- 4833M 15/850
- 850 mg / 15 mg
- 18.00 mm
- Elliptical / Oval
- Prescription only
- Drug Class
- Antidiabetic combinations
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Takeda Pharmaceuticals America, Inc.
- Inactive Ingredients
microcrystalline cellulose, croscarmellose sodium, magnesium stearate, hypromellose 2910 (6 mPa.s), polyethylene glycol 8000, titanium dioxide, magnesium silicate
Note: Inactive ingredients may vary.
Labelers / Repackagers
|NDC Code||Labeler / Repackager|
|64764-0158||Takeda Pharmaceutical Company Limited|
|00093-5050||Teva Pharmaceuticals USA, Inc.|
|54868-5553||Physicians Total Care Inc. (repackager)|
|35356-0130||Lake Erie Medical and Surgical Supply (repackager)|
Related Images for "4833M 15/850"
More about ActoPlus Met (metformin / pioglitazone)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Pricing & Coupons
- En Español
- 6 Reviews
- Generic Availability
- Drug class: antidiabetic combinations
- FDA Alerts (5)
- FDA Approval History
Other brands: ActoPlus Met XR
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.